DESAI VEERAL (Chief Strategy & Dev. Officer) sold 53.4% of their position (319.07K shares) of AGILON HEALTH, INC. on the open market
Open‑market sale worth $7.98M — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 7/11/2022ACC: 0001209191-22-041801
Officer· Chief Strategy & Dev. Officer
Since Apr 2021
-319.07K
Net shares
Net seller
$7.98M
Total sold
1
Open market trades
0B · 1S
3
Total transactions
319.07K acquired · 638.14K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+319.07K
Price / share
$1.00
Trade value
$319.07K
% of position
114.7%
7/7/2022
278.21K→597.28K
Common Stock
Direct
Shares
−319.07K
Price / share
$25.00
Trade value
$7.98M
% of position
53.4%
7/7/2022
597.28K→278.21K
Total
Net shares
+0.00
Net value
-$7.66M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/7/2022 | M · Option Exercise | +319.07K | $1.00 | $319.07K | 114.7% | 278.21K | 597.28K |
| Common Stock Direct | 7/7/2022 | S · Sale | −319.07K | $25.00 | $7.98M | 53.4% | 597.28K | 278.21K |
| Total | +0.00 | -$7.66M | ||||||
Derivative Transactions1
Options (Rights to Buy)
Direct
Converts to
Common Stock
319.07K shares
Shares
−319.07K
Strike price
1.00
Held after
137.21K
Exercisable
—
7/7/2022
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Options (Rights to Buy) Direct | Common Stock319.07K shares | 7/7/2022 | M · Option Exercise | −319.07K | 1.00 | — | 137.21K |